BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34128309)

  • 1. A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
    Rolf N; Liu LYT; Tsang A; Lange PF; Lim CJ; Maxwell CA; Vercauteren SM; Reid GSD
    Cytometry A; 2022 Jan; 101(1):57-71. PubMed ID: 34128309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia-associated aberrant immunophenotype: A flow cytometry-based experience of 110 cases from a tertiary care center in Northern India.
    Venugopalan RK; Singh N; Anthony ML; Kunnumbrath A; Gupta AK; Nath UK; Chowdhury N; Chandra H
    J Cancer Res Ther; 2023; 19(5):1335-1339. PubMed ID: 37787304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection.
    Thulasi Raman R; Anurekha M; Lakshman V; Balasubramaniam R; Ramya U; Revathi R
    Leuk Lymphoma; 2020 Aug; 61(8):1974-1980. PubMed ID: 32281503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.
    Elbnnani AS; Elbasir M; Altabal S; Lamami Y; Ebrahim F; Oshah HM; Alagnef R; Elzagheid A; Abulayha AM
    Libyan J Med; 2024 Dec; 19(1):2319895. PubMed ID: 38394044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
    Chatterjee G; Sriram H; Ghogale S; Deshpande N; Khanka T; Panda D; Pradhan SN; Girase K; Narula G; Dhamane C; Malik NR; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2021 Jul; 100(4):434-445. PubMed ID: 32896101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Fossat C; Roussel M; Arnoux I; Asnafi V; Brouzes C; Garnache-Ottou F; Jacob MC; Kuhlein E; Macintyre-Davi E; Plesa A; Robillard N; Tkaczuk J; Ifrah N; Dombret H; Béné MC; Baruchel A; Garand R;
    Cytometry B Clin Cytom; 2015 Jan; 88(1):21-9. PubMed ID: 25363877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients.
    Jalal SD; Al-Allawi NAS; Al Doski AAS
    Int J Lab Hematol; 2017 Dec; 39(6):625-632. PubMed ID: 28722319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications.
    Guglielmi C; Cordone I; Boecklin F; Masi S; Valentini T; Vegna ML; Ferrari A; Testi AM; Foa R
    Leukemia; 1997 Sep; 11(9):1501-7. PubMed ID: 9305605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
    Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
    J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry.
    Arumugam JR; Bommannan K; Radhakrishnan V; Sagar TG; Sundersingh S
    Leuk Lymphoma; 2022 Mar; 63(3):644-652. PubMed ID: 34727819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
    Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic monitoring in adults with acute lymphoblastic leukemia.
    Vidriales MB; Orfao A; San-Miguel JF
    Curr Oncol Rep; 2003 Sep; 5(5):413-8. PubMed ID: 12895394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
    Rosenberg CA; Bill M; Maguire O; Petersen MA; Kjeldsen E; Hokland P; Ludvigsen M
    Cytometry B Clin Cytom; 2022 Mar; 102(2):107-114. PubMed ID: 34648681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
    De Zen L; Bicciato S; te Kronnie G; Basso G
    Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia.
    Ouyang G; Xu Z; Jiang D; Zhu H; Wang Y; Wu W; Sun Y; Sheng L; Xu K; Lou Y; Mu Q; Zhang Y; Wu N; Cheng J; Duan S
    J Int Med Res; 2019 Apr; 47(4):1483-1492. PubMed ID: 30614357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
    Liu YR; Chang Y; Fu JY; Cheng YF; Zhang LP; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.